Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of therapeutic responses to tocilizumab in patients with rheumatoid arthritis: biomarkers identified by analysis of gene expression in peripheral blood mononuclear cells using genome-wide DNA microarray.
Sanayama Y, Ikeda K, Saito Y, Kagami S, Yamagata M, Furuta S, Kashiwakuma D, Iwamoto I, Umibe T, Nawata Y, Matsumura R, Sugiyama T, Sueishi M, Hiraguri M, Nonaka K, Ohara O, Nakajima H. Sanayama Y, et al. Among authors: umibe t. Arthritis Rheumatol. 2014 Jun;66(6):1421-31. doi: 10.1002/art.38400. Arthritis Rheumatol. 2014. PMID: 24591094
Development of a Kidney Prognostic Score in a Japanese Cohort of Patients With Antineutrophil Cytoplasmic Autoantibody Vasculitis.
Takeda R, Takahashi K, Kronbichler A, Akiyama D, Hanai S, Kobayashi Y, Matsuki A, Umibe T, Ito C, Sugimoto T, Sugiyama T, Yoshida S, Nishio Y, Nukui I, Nakashima A, Wakabayashi H, Asanuma K, Furuta S, Nakajima H, Nakagomi D. Takeda R, et al. Among authors: umibe t. Kidney Int Rep. 2024 Jan 8;9(3):611-623. doi: 10.1016/j.ekir.2024.01.007. eCollection 2024 Mar. Kidney Int Rep. 2024. PMID: 38481514 Free PMC article.
Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial.
Furuta S, Sugiyama T, Umibe T, Kaneko Y, Amano K, Kurasawa K, Nakagomi D, Hiraguri M, Hanaoka H, Sato Y, Ikeda K, Nakajima H; LoVAS Trial study investigators. Furuta S, et al. Among authors: umibe t. BMJ Open. 2017 Dec 14;7(12):e018748. doi: 10.1136/bmjopen-2017-018748. BMJ Open. 2017. PMID: 29247107 Free PMC article. Clinical Trial.
18 results